Latest news
Cyclerion Therapeutics (CYCN) outlines terms, risks and disclosures for proposed Korsana merger - Stock TitanStock Titan · Fri, 07 Aug 2026 02:37:28 GMTCyclerion Therapeutics Inc (CYCN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Wed, 05 Aug 2026 07:00:00 GMTCyclerion FY26 Q2 net loss widens to $1.76 million; revenue falls to no revenue - BitgetBitget · Tue, 04 Aug 2026 21:36:25 GMTCyclerion Therapeutics 2Q 2026: Revenue $0 Net loss $(1.76M) — 10-Q Summary - TradingViewTradingView · Tue, 04 Aug 2026 20:23:17 GMTCyclerion Therapeutics (NASDAQ: CYCN) outlines Korsana merger and going concern risk - Stock TitanStock Titan · Tue, 04 Aug 2026 20:16:39 GMTCyclerion (CYCN) and Korsana add leaders as reverse merger targets Q3 2026 close - Stock TitanStock Titan · Mon, 03 Aug 2026 21:14:31 GMTCyclerion Therapeutics Inc (CYCN) Financial Health: Profitability & Balance Sheet Analysis - TradingKeyTradingKey · Fri, 31 Jul 2026 07:00:00 GMTCYCN|Cyclerion Therapeutics Inc|Price:3.430|Chg%:-0.070 - TradingKeyTradingKey · Tue, 28 Jul 2026 07:00:00 GMT